17,400
Participants
Start Date
April 23, 2018
Primary Completion Date
December 31, 2037
Study Completion Date
December 31, 2037
Prostate cancer screening
Depending on each diagnostic test result the participants in the screening arm will undergo PSA-testing, 4Kscore determination, MRI, and MRI/US fusion biopsy only.
Helsinki University and Helsinki University Hospital, Helsinki
University of Tampere, Tampere
Collaborators (2)
Helsinki University Central Hospital
OTHER
Tampere University Hospital
OTHER
Finnish Cancer Registry, Finland
UNKNOWN
University of Turku
OTHER
Lund University
OTHER
Fimlab Laboratories, Finland
UNKNOWN
Laboratory HUSLAB, Finland
UNKNOWN
University of Helsinki
OTHER
Hospital District of Helsinki and Uusimaa
OTHER
Clinical Research Institute HUCH Ltd
OTHER
Tampere University
OTHER